Brain Fog
17
5
7
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Cognitive Task-Based Walking Effects on Cognition, Mood, Sleep, and Quality of Life in Older Adults With Brain Fog
ME/CFS Brain Fog: Cognitive Rehabilitation Trial
Long COVID Brain Fog: Cognitive Rehabilitation Trial
Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes
Effect of Daily Walnut Consumption on Memory in Subjects With Long-COVID
Investigation of the Effect of the MIND Diet on Disease Symptoms in Patients With MS
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).
Transcranial Ultrasound Stimulation for Cognitive Function Modulation in Patients With Post COVID-19 Brain Fog
Attention, Memory and Quality of Life in Post-COVID-19 Adults
Transcranial Direct Current Stimulation (tDCS)
Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning
Neural and Cognitive Consequences of COVID-19 Survival
Effect of Probiotic Strain Lactobacillus Paracasei PS23 on Brain Fog in People With Long COVID
Efficacy of Acupuncture in Patients Post-Covid Brain Fog
Stellate Ganglion Block to Treat Long COVID 19 Case Series